• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Harold S. Nelson, James William Kemp, +6 authors Miganush Stepanians
  • Medicine
  • Annals of allergy, asthma & immunology : official…
  • 2007 (First Publication: 1 August 2007)
  • BACKGROUND A controlled-release (CR) formulation of zileuton was developed to simplify administration from 600 mg 4 times daily (Zyflo) to 1,200 mg twice daily. OBJECTIVE To evaluate the efficacyExpand
  • William B. Kannel, Ralph B. D'Agostino, Miganush Stepanians, Luca D'agostino
  • Medicine
  • The American journal of cardiology
  • 1990 (First Publication: 1 September 1990)
  • This study reports the results of a 6-month, open-label multicenter study of the efficacy and tolerability of lovastatin, a 3-hydroxy-3-methylglutaryl co-enzyme A (HMG CoA) reductase inhibitor, inExpand
  • Alexandra Mangili, Julian M Falutz, Jean-Claude Mamputu, Miganush Stepanians, Brooke Particia Hayward
  • Medicine
  • PloS one
  • 2015 (First Publication: 12 October 2015)
  • Background Tesamorelin, a synthetic analog of human growth hormone-releasing factor, decreases visceral adipose tissue (VAT) in human immunodeficiency virus (HIV)-infected patients withExpand
  • Richard L Rosenthal, William H. Berger, +16 authors Edward Ellis
  • Medicine
  • American journal of rhinology
  • 1998
  • Tri-Nasal Nasal Spray is an investigational solution of triamcinolone acetonide (TAA) currently being evaluated as a treatment for allergic rhinitis. The safety and efficacy of 200 and 400 microgramsExpand
  • Richard Rosenthal, William E. Berger, +16 authors Elliot F. Ellis
  • Medicine
  • 1998 (First Publication: 1 November 1998)
  • Tri-Nasal Nasal Spray is an investigational solution of triamcinolone acetonide (TAA) currently being evaluated as a treatment for allergic rhinitis. The safety and efficacy of 200 and 400 μg onceExpand